Saranac Partners »

Eli Lilly & Co. shares owned by Saranac Partners

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Saranac Partners from 13F filings

Historical chart of Saranac Partners investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Saranac Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Saranac Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $584k 487 1199.43
2024-12-31 $244k 316 772.00

More positions owned by Saranac Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Bank of America Corporation (BAC)
Abbvie (ABBV)
Applied Materials (AMAT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ametek (AME)
TJX Companies (TJX)
UnitedHealth (UNH)
Trane Technologies SHS (TT)

View all positions for Saranac Partners

Top funds holding Eli Lilly & Co.

Lilly Endowment
BlackRock
Vanguard Capital Management
Pnc Financial Services
State Street Corporation
FMR
Capital Research Global Investors
Vanguard Portfolio Management
Geode Capital Management
Capital World Investors
Morgan Stanley
T. Rowe Price Associates
Jpmorgan Chase & Co
UBS Group
Norges Bank Investment Management

View all funds holding Eli Lilly & Co.